Perrigo is rated Hold due to a distressed balance sheet, high leverage, and unsustainable dividend coverage. PRGO's 10.9% dividend yield is not covered by free cash flow, with near-term risk of a dividend cut unless further divestitures occur. Recent asset sales, including the Dermacosmetics business, provide short-term relief but dilute margins and highlight the need for portfolio consolidation.